Scientists from EpidStrategies are attending ISPOR 2023 in Boston!
Scientists from EpidStrategies are attending ISPOR 2023 in Boston! Please reach out and connect with us and meet the newest addition to our… read more
Latest News
ToxStrategies scientists publish pre-clinical toxicity studies on cannabidiol (CBD)
ToxStrategies scientists have published two manuscripts in Food and Chemical Toxicology reporting the study design and outcome of 14- and 90-day repeat-dose oral… read more
EpidStrategies Researchers Are Presenting at the 2023 Pediatric Academic Societies Meeting
EpidStrategies, a division of ToxStrategies LLC, is excited to announce that Mina Suh, Naimisha Movva, Xiaohui Jiang, Sue Pastula, and Heidi Reichert, along… read more
ToxStrategies research into quantifying non-chemical stress in cumulative impact assessment for Environmental Justice communities
Addressing the combined role of chemical and non-chemical stressors within cumulative impact assessments is a current focus of Environmental-Justice-related research at the U.S…. read more
ToxStrategies named recipient of Research Grant to Conduct a Systematic Literature Review
ToxStrategies has been named the recipient of a research grant to conduct a systematic literature review assessing any potential relationship between formaldehyde inhalation… read more
ToxStrategies is Presenting and Exhibiting at SOT 2023
ToxStrategies is excited to be returning to present and exhibit at The Society of Toxicology’s Annual Meeting, March 19th through March 23rd. The… read more
ToxStrategies is ready to support compliance with new cosmetics regulations
The first substantial changes to FDA’s regulatory authority over cosmetics makers and products since 1938 passed Congress in December 2022, in the form… read more
New study of aspartame and cancer finds no connection
A new article published in the journal Food and Chemical Toxicology concludes that the totality of evidence does not support a link between… read more